` BBRRF (Blueberries Medical Corp) vs S&P 500 Comparison - Alpha Spread

B
BBRRF
vs
S&P 500

Over the past 12 months, BBRRF has outperformed S&P 500, delivering a return of +32% compared to the S&P 500's +13% growth.

Stocks Performance
BBRRF vs S&P 500

Loading
BBRRF
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
BBRRF vs S&P 500

Loading
BBRRF
S&P 500
Difference
www.alphaspread.com

Performance By Year
BBRRF vs S&P 500

Loading
BBRRF
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Blueberries Medical Corp vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Blueberries Medical Corp
Glance View

Market Cap
4.8m USD
Industry
Pharmaceuticals

Blueberries Medical Corp. engages in the production and distribution of psychoactive and non-psychoactive cannabis by-products. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2014-04-09. The firm is engaged in the cultivation and development of medicinal cannabis and related products. The firm is specialized in agriculture, genetics, extraction, medicine, pharmacology and marketing. Blueberries also licensed for the cultivation, production, domestic distribution, and international export of cannabidiol (CBD) and tetrahydrocannabinol (THC)-based medical cannabis.

BBRRF Intrinsic Value
0.002 USD
Overvaluation 87%
Intrinsic Value
Price
B
Back to Top